Terms: = Astrocytoma AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
256 results:
1. Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications.
Vageli DP; Doukas PG; Goupou K; Benos AD; Astara K; Zacharouli K; Sotiriou S; Ioannou M
Oncol Res; 2024; 32(8):1239-1256. PubMed ID: 39055895
[TBL] [Abstract] [Full Text] [Related]
2. Identification and validation of COL6A1 as a novel target for tumor electric field therapy in glioblastoma.
Chen J; Liu Y; Lan J; Liu H; Tang Q; Li Z; Qiu X; Hu W; Xie J; Feng Y; Qin L; Zhang X; Liu J; Chen L
CNS Neurosci Ther; 2024 Jun; 30(6):e14802. PubMed ID: 38887185
[TBL] [Abstract] [Full Text] [Related]
3. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C
Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970
[No Abstract] [Full Text] [Related]
4. LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B.
Dong N; Qi W; Wu L; Li J; Zhang X; Wu H; Zhang W; Jiang J; Zhang S; Fu W; Liu Q; Qi G; Wang L; Lu Y; Luo J; Kong Y; Liu Y; Zhao RC; Wang J
J Exp Clin Cancer Res; 2024 May; 43(1):139. PubMed ID: 38725030
[TBL] [Abstract] [Full Text] [Related]
5. VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis.
Guo M; Zhang J; Han J; Hu Y; Ni H; Yuan J; Sun Y; Liu M; Gao L; Liao W; Ma C; Liu Y; Li S; Li N
J Transl Med; 2024 May; 22(1):419. PubMed ID: 38702818
[TBL] [Abstract] [Full Text] [Related]
6. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
[TBL] [Abstract] [Full Text] [Related]
7. CD133 significance in glioblastoma development: in silico and in vitro study.
Abdoli Shadbad M; Nejadi Orang F; Baradaran B
Eur J Med Res; 2024 Mar; 29(1):154. PubMed ID: 38448914
[TBL] [Abstract] [Full Text] [Related]
8. Exploring the therapeutic mechanisms and prognostic targets of Biochanin A in glioblastoma via integrated computational analysis and in vitro experiments.
Ge W; Yuan G; Wang D; Dong L
Sci Rep; 2024 Feb; 14(1):3783. PubMed ID: 38360888
[TBL] [Abstract] [Full Text] [Related]
9. Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating akt1 signaling.
Wang B; Zhang X; Li ZS; Wei C; Yu RZ; Du XZ; He YJ; Ren Y; Zhen YW; Han L
Cancer Lett; 2024 Mar; 585():216665. PubMed ID: 38290657
[TBL] [Abstract] [Full Text] [Related]
10. Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma.
Shaikh MAJ; Altamimi ASA; Afzal M; Gupta G; Singla N; Gilhotra R; Almalki WH; Kazmi I; Alzarea SI; Prasher P; Singh SK; Dua K
Pathol Res Pract; 2024 Feb; 254():155121. PubMed ID: 38262269
[TBL] [Abstract] [Full Text] [Related]
11. Inhibitory Effects of Urolithins, Bioactive Gut Metabolites from Natural Polyphenols, against Glioblastoma Progression.
Shen CK; Huang BR; Charoensaensuk V; Yang LY; Tsai CF; Liu YS; Lai SW; Lu DY; Yeh WL; Lin C
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068712
[TBL] [Abstract] [Full Text] [Related]
12. STEAP3 is a prognostic biomarker that promotes glioma progression by regulating immune microenvironment and PI3K-akt pathway.
Song Z; Zhao Z; Zhu S; Jin Q; Shi Y; Zhang S; Wang Z; Wang Y; Zhao Z
Cancer Biomark; 2023; 38(4):505-522. PubMed ID: 37980651
[TBL] [Abstract] [Full Text] [Related]
13. ABCF1/CXCL12/CXCR4 Enhances Glioblastoma Cell Proliferation, Migration, and Invasion by Activating the PI3K/akt Signal Pathway.
Yin X; Xia K; Peng S; Tan B; Huang Y; Wang M; He M
Dev Neurosci; 2024; 46(3):210-220. PubMed ID: 37757768
[TBL] [Abstract] [Full Text] [Related]
14. Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/akt Signaling Pathways.
Li H; Liu J; Qin X; Sun J; Liu Y; Jin F
Cell Mol Neurobiol; 2023 Nov; 43(8):3929-3942. PubMed ID: 37747595
[TBL] [Abstract] [Full Text] [Related]
15. Glioblastoma cellular MAP4K1 facilitates tumor growth and disrupts T effector cell infiltration.
Sun JM; Fan HY; Zhu Y; Pan TT; Wu YP; Zhang DY; Hou XY
Life Sci Alliance; 2023 Dec; 6(12):. PubMed ID: 37734869
[TBL] [Abstract] [Full Text] [Related]
16. Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/akt pathway.
Liang W; Liu M; Su Y; Wen Y; Wang L; Shan J; Zhao J; Xie K; Wang J
IUBMB Life; 2024 Mar; 76(3):140-160. PubMed ID: 37728571
[TBL] [Abstract] [Full Text] [Related]
17. Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC.
Zheng SX; Chen J; Zhuang BB; Zhang Q; Shi SS; Zhang GL
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16055-16067. PubMed ID: 37695389
[TBL] [Abstract] [Full Text] [Related]
18. Toward Precision Oncology in Glioblastoma with a Personalized Cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing.
Erdogan O; Özkaya ŞÇ; Erzik C; Bilguvar K; Arga KY; Bayraklı F
OMICS; 2023 Sep; 27(9):426-433. PubMed ID: 37669106
[TBL] [Abstract] [Full Text] [Related]
19. SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway.
Li C; Chen B; Zhang J; Yang J; Guo M; Ren Y; Zhou Z; Fung KM; Li M; Zhang L; Liu Z
Cancer Lett; 2023 Nov; 577():216368. PubMed ID: 37652287
[TBL] [Abstract] [Full Text] [Related]
20. NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/akt/mTOR/Snail pathway.
Zheng L; Yang S; Xu R; Yang Y; Quan J; Lin Z; Quan C
Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594082
[TBL] [Abstract] [Full Text] [Related]
[Next]
